Skip to main content
TipRanks
Go Ultimate75% OFF

Alkyl Amines Chemicals Limited (ALKYLAMINE) AI Stock Analysis

3 Followers
IN:ALKYLAMINE

Alkyl Amines Chemicals Limited

(NSE:ALKYLAMINE)

Select Model
Rating:69Neutral
Price Target:INR 1,723.00â–²(6.73% Upside)
Action:reiterated
Date:10/07/26

The score is primarily supported by strong financial resilience (very low leverage and generally positive cash generation). Technicals are moderately constructive with price above key moving averages, but weakened momentum (negative MACD) tempers the outlook. The biggest drag is valuation, with a high P/E and low dividend yield requiring stronger earnings momentum to justify the price.

Positive Factors
Very Low LeverageMinimal debt reduces financial risk and preserves flexibility for capital spending, working capital needs, or strategic growth. This conservative balance-sheet structure also gives the company greater resilience if demand weakens or profitability remains below the stronger levels seen in earlier years.
Negative Factors
Inconsistent Revenue GrowthUneven revenue performance, including declines in two recent years, signals that demand or selling conditions have not remained consistently supportive. Persistently irregular top-line growth can limit operating leverage, make earnings harder to forecast, and weaken the pace at which the business compounds.

Alkyl Amines Chemicals Limited (ALKYLAMINE) vs. iShares MSCI India ETF (INDA)

-40%-30%-20%-10%0%10%20%IN:ALKYLAMINE-8.46%INDA-4.82%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Market Cap
INR 82.97B
Dividend Yield
0.62%
Average Volume (3M)
6,551
Price to Earnings (P/E)
33.2
Beta (1Y)
0.89
Revenue Growth
13.38%
EPS Growth
35.82%
Country
India
Employees
692
Sector
General
Sector Strength
55
Industry
Chemicals - Specialty

Alkyl Amines Chemicals Limited Business Overview & Revenue Model

Company Description

Alkyl Amines Chemicals Limited functions as a global producer and purveyor of a diverse portfolio of chemical substances, encompassing various amines, their derivatives, and a selection of specialized chemicals. The company's offerings include alipha...

Alkyl Amines Chemicals Limited Financial Statement Overview

Summary

Overall fundamentals are supported by an exceptionally conservative balance sheet (minimal debt, strong flexibility) and generally positive operating cash generation. Offsetting this, profitability and returns have cooled from the 2021–2023 peak, gross margins have compressed, and revenue growth has become inconsistent (including declines in 2024 and 2026), indicating softer momentum versus the prior cycle.

Income Statement

63Positive

Balance Sheet

92Very Positive

Cash Flow

70Positive
Financial statement breakdown
BreakdownTTMMar 2026Mar 2025Mar 2024Mar 2023Mar 2022
Income Statement
Total Revenue9.15B15.36B15.72B14.41B16.83B15.42B
Gross Profit3.83B5.35B7.14B6.54B8.04B6.92B
EBITDA2.22B3.16B2.98B2.55B3.49B3.27B
Net Income1.40B1.80B1.86B1.49B2.29B2.25B
Balance Sheet
Total Assets018.95B17.89B15.84B15.90B13.71B
Cash, Cash Equivalents and Short-Term Investments2.51B2.51B2.03B303.92M171.95M615.33M
Total Debt011.90M55.20M31.68M877.50M232.89M
Total Liabilities-15.33B3.62B3.86B3.16B4.21B3.82B
Stockholders Equity15.33B15.33B14.02B12.67B11.69B9.90B
Cash Flow
Free Cash Flow01.10B2.15B1.53B-550.40M-422.81M
Operating Cash Flow02.39B2.63B2.75B2.48B2.05B
Investing Cash Flow0-1.37B-1.96B-1.21B-2.77B-2.06B
Financing Cash Flow0-560.90M-491.50M-1.40B80.00M-572.89M

Alkyl Amines Chemicals Limited Technical Analysis

Technical Analysis SentimentNegative
Last Price1614.30

Price Trends

50DMA1813.24Negative
100DMA1840.02Negative
200DMA1685.38Negative

Market Momentum

MACD-65.52Positive
RSI40.43Neutral
STOCH22.77Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:ALKYLAMINE, the sentiment is Negative. The current price of 1614.30 is below the 20-day moving average (MA) of 1695.53, below the 50-day MA of 1813.24, and below the 200-day MA of 1685.38, indicating a bearish trend. The MACD of -65.52 indicates Positive momentum. The RSI at 40.43 is Neutral, neither overbought nor oversold. The STOCH value of 22.77 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for IN:ALKYLAMINE.

Alkyl Amines Chemicals Limited Peers Comparison

Overall Rating

UnderperformOutperform
Sector (55)

Financial Indicators

IN:ALKYLAMINE against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
IN:VINATIORGAIN:VINATIORGA70OutperformINR 110.31B27.83―0.77%10.98%-5.48%
IN:ALKYLAMINEIN:ALKYLAMINE69NeutralINR 82.84B33.18―0.62%13.38%35.82%
IN:BALAMINESIN:BALAMINES56NeutralINR 58.20B24.85―0.61%20.91%62.44%
Sector *55Neutral$6.65B3.83-15.92%6.20%10.91%7.18%
IN:AARTIINDIN:AARTIIND47NeutralINR 166.59B29.54―0.21%39.85%103.71%
IN:JUBLINGREAIN:JUBLINGREA46NeutralINR 93.41B26.99―0.83%15.41%21.76%
IN:LXCHEMIN:LXCHEM46NeutralINR 45.19B26.66―0.18%21.34%105.39%

* General Sector Average

Performance Comparison

0%50%100%IN:ALKYLAMINEIN:AARTIINDIN:BALAMINESIN:JUBLINGREAIN:LXCHEMIN:VINATIORGADec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
IN:ALKYLAMINE and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
IN:ALKYLAMINEAlkyl Amines Chemicals Limited1614.30-153.23-8.67%
IN:AARTIINDAARTI Industries Ltd484.3091.7323.37%
IN:BALAMINESBalaji Amines Limited1822.45568.4145.33%
IN:JUBLINGREAJubilant Ingrevia Ltd.599.10-77.25-11.42%
IN:LXCHEMLaxmi Organic Industries Ltd.165.15-23.03-12.24%
IN:VINATIORGAVinati Organics Limited1105.50-540.34-32.83%

Alkyl Amines Chemicals Limited Corporate Events

Alkyl Amines shareholders clear board restructuring and leadership extensions

Sep 21, 2026

Alkyl Amines Chemicals Limited has secured shareholder approval via postal ballot and remote e-voting for a suite of special resolutions that reshape its senior leadership structure. Key changes include the re-designation of Yogesh M. Kothari as Exec...

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Oct 07, 2026